Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.

    New Study Highlights a Protein With the Potential to Predict Cancer Deaths and Type 2 Diabetes Risk

    Inside Precision Medicine recently featured an article describing a study that was published in the European journal Diabetologia conducted by a team of Chinese and Swedish researchers. The study suggested…

    Continue Reading New Study Highlights a Protein With the Potential to Predict Cancer Deaths and Type 2 Diabetes Risk

    British Researchers Announce Positive Results from New Study of Potentially Curative Treatment for Hemophilia Patients

    According to a recent article in the British publication Latest Page News, doctors at the University College in London and Royal Free London believe that a ‘cure’ is possible within…

    Continue Reading British Researchers Announce Positive Results from New Study of Potentially Curative Treatment for Hemophilia Patients
    Experimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    source: pixabay.com

    Experimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

      Researchers acknowledge that the primary cause of failure of stem cell transplants is disease relapse. This holds true specifically for allogeneic hematopoietic stem cell transplants where a cancer patient…

    Continue Reading Experimental Treatment Combination Shows Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Compassion Corner: Balancing Compassion with Objectivity; Benefits to Patients and Doctors
    source: pixabay.com

    Compassion Corner: Balancing Compassion with Objectivity; Benefits to Patients and Doctors

      Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is…

    Continue Reading Compassion Corner: Balancing Compassion with Objectivity; Benefits to Patients and Doctors

    Fibrodysplasia Ossificans Progressiva: A Rare Disease That Turns The Body Into Bone

      Fibrodysplasia ossificans progressiva (FOP) begins with very little warning. When children are born with FOP, they appear normal aside from a possibly characteristic malformation of the largest toe that…

    Continue Reading Fibrodysplasia Ossificans Progressiva: A Rare Disease That Turns The Body Into Bone
    Their Daughter’s Diagnosis: Ataxia-Telangiectasia. The Treatment: Physical Therapy, Medication, and Love
    source: pixabay.com

    Their Daughter’s Diagnosis: Ataxia-Telangiectasia. The Treatment: Physical Therapy, Medication, and Love

    The Catawba Virginia Farmers Market’s mission is to provide the Catawba community with  local produce and handicrafts. Stephanie and Donald Schneider owners of Pacaberry Farms have been vendors at the…

    Continue Reading Their Daughter’s Diagnosis: Ataxia-Telangiectasia. The Treatment: Physical Therapy, Medication, and Love

    ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity

      Dr. Cecilia Chung and associates at the Vanderbilt University’s Medical Center conducted a study published recently in MedPage Today. Results showed that patients who had inflammatory disorders, as well…

    Continue Reading ICYMI: Patients with a Certain Genotype Are More Likely to Discontinue Imuran Due to Toxicity
    Results From This Study are Encouraging for Alpha-1 Antitrypsin Deficiency Liver Disease
    source: pixabay.com

    Results From This Study are Encouraging for Alpha-1 Antitrypsin Deficiency Liver Disease

      Takeda and its collaborator, Arrowhead Pharmaceuticals, recently announced results from AROAAT-2002 of the investigational drug fazirsiran. The drug is an RNA interference therapeutic developed to lessen alpha-1 antitirypsin protein…

    Continue Reading Results From This Study are Encouraging for Alpha-1 Antitrypsin Deficiency Liver Disease
    Nebraskans for Medical Marijuana Are Running Out of Time to Put Petitions on the Ballot Before November
    source: pixabay.com

    Nebraskans for Medical Marijuana Are Running Out of Time to Put Petitions on the Ballot Before November

      As time runs out, volunteer Dominic Gillen is running even harder. In an interview with KETV, he admits that they are not yet where they should be in order…

    Continue Reading Nebraskans for Medical Marijuana Are Running Out of Time to Put Petitions on the Ballot Before November
    A Mother’s Last Hope to Save Her Daughter’s Life
    source: pixabay.com

    A Mother’s Last Hope to Save Her Daughter’s Life

      CBC News Canada carried the story of a 23-year-old patient, Morgan Buyaki of Saskatchewan, Canada, who was diagnosed eighteen months ago with eosinophilic granulomatosis with polyangiitis (EGPA). Morgan’s mother…

    Continue Reading A Mother’s Last Hope to Save Her Daughter’s Life

    Researchers Created Mini-Kidneys to Identify Tuberous Sclerosis Complex and Solve a Medical Mystery

    Tuberous sclerosis complex (TSC) is classified as a rare genetic disorder that causes typically benign tumors in the brain, skin, heart, kidneys, or lungs. As described in a recent article…

    Continue Reading Researchers Created Mini-Kidneys to Identify Tuberous Sclerosis Complex and Solve a Medical Mystery

    The European Commission Has Approved Pembrolizumab (Keytruda) to Treat Resected Stage IIB and IIC Melanoma

    According to a press release by Merck & Co. issued on June 24, the European Commission has approved the use of adjuvant Pembrolizumab to treat resected stage IIB/C melanoma. "Adjuvant"…

    Continue Reading The European Commission Has Approved Pembrolizumab (Keytruda) to Treat Resected Stage IIB and IIC Melanoma
    ICYMI: Trabectedin for Ovarian Cancer Did Not Meet its Primary Endpoint
    source: pixabay.com

    ICYMI: Trabectedin for Ovarian Cancer Did Not Meet its Primary Endpoint

      Findings from the MITO23 Trial investigating the outcome of the chemotherapy drug trabectedin against physician’s choice to treat BRCA-mutated patients with ovarian cancer were presented at ASCO’s 2022 Annual…

    Continue Reading ICYMI: Trabectedin for Ovarian Cancer Did Not Meet its Primary Endpoint
    ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy
    source: pixabay.com

    ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy

      The patient, age 82, had recovered from a stroke several months ago. According to a recent article reported on dnyuz.com and originally published in the New York Times, the…

    Continue Reading ICYMI: His Doctors Finally Discovered the Cause of His Immune-Mediated Necrotizing Myopathy